Shin J - Search Results

1

DNA-binding Cell-penetrating Peptide-based TRAIL Over-expression in Adipose Tissue-derived Mesenchymal Stem Cells Inhibits Glioma U251MG Growth.

Shin J, Baik SK, Yoon Y, Hwang S, Sohn JH, Jo M, Kim WS, Rhee KJ, Whang K, Eom YW. Shin J, et al. Anticancer Res. 2021 Jun;41(6):2859-2866. doi: 10.21873/anticanres.15067. Anticancer Res. 2021. PMID: 34083276

2

CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.

Hong JK, Kim DY, Shin JS, Ryu YS, Moon JH, Koh DI, Lee S, Lee J, Lee WJ, Lee EY, Jung SA, Kim SC, Yu HN, Kim MJ, Hong SW, Park SS, Jung J, Kim SM, Kim EH, Jeong HR, Gong JH, Kim J, Kim TW, Jin DH. Hong JK, et al. Among authors: shin js. Anticancer Res. 2022 Apr;42(4):1813-1819. doi: 10.21873/anticanres.15657. Anticancer Res. 2022. PMID: 35346999

3

The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2.

Yoon DH, Shin JS, Jin DH, Hong SW, Jung KA, Kim SM, Hong YS, Kim KP, Lee JL, Suh C, Lee JS, Kim TW. Yoon DH, et al. Anticancer Res. 2012 May;32(5):1681-8. Anticancer Res. 2012. PMID: 22593446

4

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.

Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH. Moon JH, et al. Among authors: shin js. Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4. Br J Cancer. 2019. PMID: 30944457 Free PMC article.

5

Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.

Kim DM, Kim MJ, Moon JH, Lee EY, Hong JK, Lee S, Koh DI, Ryu YS, Kim SM, Jung SA, Shin JS, Kim J, Park YS, Hong SW, Lee SH, Jung J, Park SS, Kim DY, Kim EH, Jeong HR, Gong JH, Kim J, Chan Kim S, Yu HN, Ki SY, Kim TW, Jin DH. Kim DM, et al. Among authors: shin js. Biochem Biophys Res Commun. 2020 Jun 18;527(1):305-310. doi: 10.1016/j.bbrc.2020.04.095. Epub 2020 May 11. Biochem Biophys Res Commun. 2020. PMID: 32446385

6

NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants.

Shin JS, Hong SW, Moon JH, Kim JS, Jung KA, Kim SM, Lee DH, Kim I, Yoon SJ, Lee CG, Choi EK, Lee JY, Kim KP, Hong YS, Lee JL, Kim B, Choi EK, Lee JS, Jin DH, Kim TW. Shin JS, et al. Invest New Drugs. 2014 Jun;32(3):389-99. doi: 10.1007/s10637-013-0039-4. Epub 2013 Oct 31. Invest New Drugs. 2014. PMID: 24173966

7

Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells.

Jung YD, Park SK, Kang D, Hwang S, Kang MH, Hong SW, Moon JH, Shin JS, Jin DH, You D, Lee JY, Park YY, Hwang JJ, Kim CS, Suh N. Jung YD, et al. Redox Biol. 2020 Oct;37:101716. doi: 10.1016/j.redox.2020.101716. Epub 2020 Sep 9. Redox Biol. 2020. PMID: 32961441 Free PMC article.

8

p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies.

Hong SW, Kim CJ, Park WS, Shin JS, Lee SD, Ko SG, Jung SI, Park IC, An SK, Lee WK, Lee WJ, Jin DH, Lee MS. Hong SW, et al. Cancer Res. 2009 Feb 1;69(3):741-6. doi: 10.1158/0008-5472.CAN-08-1189. Epub 2009 Jan 27. Cancer Res. 2009. PMID: 19176394

9

L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.

Jung SA, Lee DH, Moon JH, Hong SW, Shin JS, Hwang IY, Shin YJ, Kim JH, Gong EY, Kim SM, Lee EY, Lee S, Kim JE, Kim KP, Hong YS, Lee JS, Jin DH, Kim T, Lee WJ. Jung SA, et al. Free Radic Biol Med. 2016 Jun;95:200-8. doi: 10.1016/j.freeradbiomed.2016.03.009. Epub 2016 Mar 22. Free Radic Biol Med. 2016. PMID: 27012422

10

SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.

Choi EK, Kim SM, Hong SW, Moon JH, Shin JS, Kim JH, Hwang IY, Jung SA, Lee DH, Lee EY, Lee S, Kim H, Kim D, Kim YS, Choi YK, Kim HI, Choi HS, Cho SG, Kim JE, Kim KP, Hong YS, Lee WK, Lee JS, Kim TW, Ko SG, Jin DH. Choi EK, et al. Mol Med Rep. 2016 Oct;14(4):3955-60. doi: 10.3892/mmr.2016.5722. Epub 2016 Sep 6. Mol Med Rep. 2016. PMID: 27599791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,150 results

Search Page